Suppr超能文献

MicroRNA-29a 通过调控 PDGF 通路抑制脑胶质瘤干细胞及肿瘤生长。

MicroRNA-29a inhibits glioblastoma stem cells and tumor growth by regulating the PDGF pathway.

机构信息

Department of Microbiology, Immunology and Cancer Biology, University of Virginia, PO Box 800168, Charlottesville, VA, 22908, USA.

Neurosurgical Research, University Clinics Munich, Munich, Germany.

出版信息

J Neurooncol. 2019 Oct;145(1):23-34. doi: 10.1007/s11060-019-03275-z. Epub 2019 Sep 3.

Abstract

BACKGROUND AND PURPOSE

microRNAs are small noncoding RNAs that play important roles in cancer regulation. In this study, we investigated the expression, functional effects and mechanisms of action of microRNA-29a (miR-29a) in glioblastoma (GBM).

METHODS

miR-29a expression levels in GBM cells, stem cells (GSCs) and human tumors as well as normal astrocytes and normal brain were measured by quantitative PCR. miR-29a targets were uncovered by target prediction algorithms, and verified by immunoblotting and 3' UTR reporter assays. The effects of miR-29a on cell proliferation, death, migration and invasion were assessed with cell counting, Annexin V-PE/7AAD flow cytometry, scratch assay and transwell assay, respectively. Orthotopic xenografts were used to determine the effects of miR-29a on tumor growth.

RESULTS

Mir-29a was downregulated in human GBM specimens, GSCs and GBM cell lines. Exogenous expression of miR-29a inhibited GSC and GBM cell growth and induced apoptosis. miR-29a also inhibited GBM cell migration and invasion. PDGFC and PDGFA were uncovered and validated as direct targets of miR-29a in GBM. miR-29a downregulated PDGFC and PDGFA expressions at the transcriptional and translational levels. PDGFC and PDGFA expressions in GBM tumors, GSCs, and GBM established cell lines were higher than in normal brain and human astrocytes. Mir-29a expression inhibited orthotopic GBM xenograft growth.

CONCLUSIONS

miR-29a is a tumor suppressor miRNA in GBM, where it inhibits cancer stem cells and tumor growth by regulating the PDGF pathway.

摘要

背景与目的

微小 RNA 是在癌症调控中发挥重要作用的小非编码 RNA。在这项研究中,我们研究了 microRNA-29a(miR-29a)在胶质母细胞瘤(GBM)中的表达、功能效应和作用机制。

方法

通过定量 PCR 测量 GBM 细胞、干细胞(GSCs)和人肿瘤以及正常星形胶质细胞和正常脑内的 miR-29a 表达水平。通过靶标预测算法发现 miR-29a 的靶标,并通过免疫印迹和 3'UTR 报告基因检测进行验证。通过细胞计数、Annexin V-PE/7AAD 流式细胞术、划痕试验和 Transwell 试验分别评估 miR-29a 对细胞增殖、死亡、迁移和侵袭的影响。使用原位异种移植来确定 miR-29a 对肿瘤生长的影响。

结果

miR-29a 在人 GBM 标本、GSCs 和 GBM 细胞系中下调。外源性表达 miR-29a 抑制 GSC 和 GBM 细胞生长并诱导细胞凋亡。miR-29a 还抑制 GBM 细胞迁移和侵袭。发现并验证 PDGFC 和 PDGFA 是 GBM 中 miR-29a 的直接靶标。miR-29a 在转录和翻译水平下调 PDGFC 和 PDGFA 的表达。GBM 肿瘤、GSCs 和 GBM 建立的细胞系中的 PDGFC 和 PDGFA 表达高于正常脑和人星形胶质细胞。miR-29a 的表达抑制了原位 GBM 异种移植的生长。

结论

miR-29a 是 GBM 中的肿瘤抑制 miRNA,通过调节 PDGF 途径抑制癌症干细胞和肿瘤生长。

相似文献

1
MicroRNA-29a inhibits glioblastoma stem cells and tumor growth by regulating the PDGF pathway.
J Neurooncol. 2019 Oct;145(1):23-34. doi: 10.1007/s11060-019-03275-z. Epub 2019 Sep 3.
4
MicroRNA-377 inhibited proliferation and invasion of human glioblastoma cells by directly targeting specificity protein 1.
Neuro Oncol. 2014 Nov;16(11):1510-22. doi: 10.1093/neuonc/nou111. Epub 2014 Jun 20.
5
MiR-449a exerts tumor-suppressive functions in human glioblastoma by targeting Myc-associated zinc-finger protein.
Mol Oncol. 2015 Mar;9(3):640-56. doi: 10.1016/j.molonc.2014.11.003. Epub 2014 Nov 20.
7
Knockdown of long non-coding RNA XIST exerts tumor-suppressive functions in human glioblastoma stem cells by up-regulating miR-152.
Cancer Lett. 2015 Apr 1;359(1):75-86. doi: 10.1016/j.canlet.2014.12.051. Epub 2015 Jan 8.
9
Oncogenic effects of miR-10b in glioblastoma stem cells.
J Neurooncol. 2013 Apr;112(2):153-63. doi: 10.1007/s11060-013-1047-0. Epub 2013 Jan 10.

引用本文的文献

2
The role of RNA methylation in glioma progression: mechanisms, diagnostic implications, and therapeutic value.
Front Immunol. 2025 May 21;16:1583039. doi: 10.3389/fimmu.2025.1583039. eCollection 2025.
3
Targeting miR-103a-3p/IGFBP5 axis: a potential therapeutic strategy for gastric cancer progression.
Discov Oncol. 2025 Apr 22;16(1):591. doi: 10.1007/s12672-025-02390-w.
5
Use of microRNAs as Diagnostic, Prognostic, and Therapeutic Tools for Glioblastoma.
Int J Mol Sci. 2024 Feb 20;25(5):2464. doi: 10.3390/ijms25052464.
6
HSV1 microRNAs in glioblastoma development: an in silico study.
Sci Rep. 2024 Jan 2;14(1):27. doi: 10.1038/s41598-023-45249-2.
9
Non-coding RNAs and glioma: Focus on cancer stem cells.
Mol Ther Oncolytics. 2022 Sep 17;27:100-123. doi: 10.1016/j.omto.2022.09.005. eCollection 2022 Dec 15.
10
Molecular Pathways and Genomic Landscape of Glioblastoma Stem Cells: Opportunities for Targeted Therapy.
Cancers (Basel). 2022 Jul 31;14(15):3743. doi: 10.3390/cancers14153743.

本文引用的文献

1
MicroRNA-29a activates a multi-component growth and invasion program in glioblastoma.
J Exp Clin Cancer Res. 2019 Jan 25;38(1):36. doi: 10.1186/s13046-019-1026-1.
2
MiR-29a-Mediated CD133 Expression Contributes to Cisplatin Resistance in CD133 Glioblastoma Stem Cells.
J Mol Neurosci. 2018 Nov;66(3):369-377. doi: 10.1007/s12031-018-1177-0. Epub 2018 Sep 29.
3
MiR-29a Inhibits Glioma Tumorigenesis through a Negative Feedback Loop of TRAF4/Akt Signaling.
Biomed Res Int. 2018 Aug 14;2018:2461363. doi: 10.1155/2018/2461363. eCollection 2018.
4
PDGF/PDGFR axis in the neural systems.
Mol Aspects Med. 2018 Aug;62:63-74. doi: 10.1016/j.mam.2018.01.006. Epub 2018 Feb 6.
5
miR-29a/b/c function as invasion suppressors for gliomas by targeting CDC42 and predict the prognosis of patients.
Br J Cancer. 2017 Sep 26;117(7):1036-1047. doi: 10.1038/bjc.2017.255. Epub 2017 Aug 8.
7
PDGFs and their receptors.
Gene. 2017 May 30;614:1-7. doi: 10.1016/j.gene.2017.03.003. Epub 2017 Mar 4.
9
miR-29s inhibit the malignant behavior of U87MG glioblastoma cell line by targeting DNMT3A and 3B.
Neurosci Lett. 2015 Mar 17;590:40-6. doi: 10.1016/j.neulet.2015.01.060. Epub 2015 Jan 24.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验